Supplement

You have full text access to this OnlineOpen article

Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003†‡

  1. Brenda Y. Hernandez PhD, MPH1,§,*,
  2. Jill Barnholtz-Sloan PhD2,
  3. Robert R. German DrPH, MPH3,
  4. Anna Giuliano PhD4,
  5. Marc T. Goodman PhD, MPH1,
  6. Jessica B. King MPH3,
  7. Serban Negoita MD, MPH5,
  8. Jose M. Villalon-Gomez MD, MPH6

Article first published online: 3 NOV 2008

DOI: 10.1002/cncr.23743

Issue

Cancer

Cancer

Supplement: Assessing the Burden of HPV-Associated Cancers in the United States

Volume 113, Issue Supplement 10, pages 2883–2891, 15 November 2008

Additional Information

How to Cite

Hernandez, B. Y., Barnholtz-Sloan, J., German, R. R., Giuliano, A., Goodman, M. T., King, J. B., Negoita, S. and Villalon-Gomez, J. M. (2008), Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer, 113: 2883–2891. doi: 10.1002/cncr.23743

Author Information

  1. 1

    Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii

  2. 2

    Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio

  3. 3

    Centers for Disease Control and Prevention, Atlanta, Georgia

  4. 4

    H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

  5. 5

    Center for Community Health, New York State Department of Health, Albany, New York

  6. 6

    Jamaica Hospital Family Medicine Residency Program, Mount Sinai School of Medicine, Queens, New York

  1. §

    Fax: (808) 586-2982.

*Cancer Research Center of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813

  1. †

    The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

  2. ‡

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 3 NOV 2008
  2. Article first published online: 3 NOV 2008
  3. Manuscript Accepted: 16 MAY 2008
  4. Manuscript Received: 14 APR 2008

Funded by

  • Cooperative Agreement. Grant Number: U50 DP424071-04
  • Centers for Disease Control and Prevention
  • advisory committee and speakers bureau of Merck

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (161K)

REFERENCES

  • 1
    Parkin DM,Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006; 24( suppl 3): S11–S25.
  • 2
    Muir CS,Nectoux J. Epidemiology of cancer of the testis and penis. Natl Cancer Inst Monogr. November 1979; 157–164.
  • 3
    Rippentrop JM,Joslyn SA,Konety BR. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004; 101: 1357–1363.
    Direct Link:
  • 4
    Barnholtz-Sloan JS,Maldonado JL,Pow-sang J,Guiliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007; 25: 361–367.
  • 5
    Goodman MT,Hernandez BY,Shvetsov YB. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1833–1839.
  • 6
    Daling JR,Madeleine MM,Johnson LG, et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005; 116: 606–616.
    Direct Link:
  • 7
    Rubin MA,Kleter B,Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol. 2001; 159: 1211–1218.
  • 8
    Lont AP,Kroon BK,Horenblas S, et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer. 2006; 119: 1078–1081.
    Direct Link:
  • 9
    Senba M,Kumatori A,Fujita S, et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J Med Virol. 2006; 78: 1341–1346.
    Direct Link:
  • 10
    Picconi MA,Eijan AM,Distefano AL, et al. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol. 2000; 61: 65–69.
    Direct Link:
  • 11
    Bezerra AL,Lopes A,Santiago GH,Ribeiro KC,Latorre MR,Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001; 91: 2315–2321.
    Direct Link:
  • 12
    Bezerra AL,Lopes A,Landman G,Alencar GN,Torloni H,Villa LL. Clinicopathologic features and human papillomavirus dna prevalence of warty and squamous cell carcinoma of the penis. Am J Surg Pathol. 2001; 25: 673–678.
  • 13
    Heideman DA,Waterboer T,Pawlita M, et al. Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol. 2007; 25: 4550–4556.
  • 14
    World Health Organization. HPV IARC monograph summary. Lancet Oncol. 2005; 6: 204.
  • 15
    Maden C,Sherman KJ,Beckmann AM, et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst. 1993; 85: 19–24.
  • 16
    Carter JJ,Madeleine MM,Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res. 2001; 61: 1934–1940.
  • 17
    Tsen HF,Morgenstern H,Mack T,Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001; 12: 267–277.
  • 18
    World Health Organization. International Classification of Disease for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2003.
  • 19
    American College of Surgeons Commission on Cancer. Registry Operations and Data Standards (ROADS). Standards of the Commission on Cancer. Chicago, IL: American College of Surgeons; 1996.
  • 20
    Howe HL,Jamison PM,Havener L,Chen VW,Ries LAG. Site-specific comparison of summary stage 1977 and summary stage 2000 coding. Available at:http://www.naaccr.org/indexasp?Col_SectionKey=11&Col_ContentID=397 2008 Accessed on June 6, 2007.
  • 21
    Berg J. Morphologic classification of human cancer. In: SchottenfeldD,FraumeniJJ, eds. Cancer Epidemiology and Prevention.2nd ed. New York, NY: Oxford University Press; 1996: 28–44.
  • 22
    Watson M,Saraiya M,Ahmed F, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the United States: overview of methods. Cancer. 2008; 113(10 suppl ): 2841–2854.
    Direct Link:
  • 23
    Dunne EF,Nielson CM,Stone KM,Markowitz LE,Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006; 194: 1044–1057.
  • 24
    Xu F,Markowitz LE,Sternberg MR,Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis. 2007; 34: 479–484.
  • 25
    Svare EI,Kjaer SK,Worm AM,Osterlind A,Meijer CJ,van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect. 2002; 78: 215–218.
  • 26
    Vaccarella S,Lazcano-Ponce E,Castro-Garduno JA, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer. 2006; 119: 1934–1939.
    Direct Link:
  • 27
    Castellsague X,Bosch FX,Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002; 346: 1105–1112.
  • 28
    Baldwin SB,Wallace DR,Papenfuss MR,Abrahamsen M,Vaught LC,Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis. 2004; 31: 601–607.
  • 29
    Hernandez B,Wilkens L,Zhu X, et al. Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis. 2008; 197: 787–794.
  • 30
    Brinton LA,Li JY,Rong SD, et al. Risk factors for penile cancer: results from a case-control study in China. Int J Cancer. 1991; 47: 504–509.
    Direct Link:
  • 31
    Kahn JA,Lan D,Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007; 110: 87–95.
  • 32
    Ries LAG,Melbert D,Krapcho M, et al.SEER Cancer Statistics Review, 1975-2004. Based on November 2006 SEER data submission, posted to the SEER website 2007. Available at: http://seer.cancer.gov/csr/1975_2004/ Accessed on June 6, 2007.
  • 33
    Maiche AG,Pyrhonen S. Clinical staging of cancer of the penis: by size? By localization? Or by depth of infiltration? Eur Urol. 1990; 18: 16–22.
  • 34
    Micali G,Nasca MR,Innocenzi D,Schwartz RA. Penile cancer. J Am Acad Dermatol. 2006; 54: 369–391.
  • 35
    McDougal WS. Advances in the treatment of carcinoma of the penis. Urology. 2005; 66( 5 suppl): 114–117.
  • 36
    Goodman MT,Shvetsov YB,McDuffie K, et al. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res. 2007; 67: 5987–5996.
  • 37
    Goldie SJ,Kohli M,Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst. 2004; 96: 604–615.
View Full Article (HTML) Get PDF (161K)